Status:
COMPLETED
New Biopsy Needle - Evaluation of Prostate Biopsy Quality
Lead Sponsor:
Region Skane
Conditions:
Prostate Cancer (Diagnosis)
Eligibility:
MALE
40-90 years
Phase:
NA
Brief Summary
Patient blinded randomized prospective trial evaluating prostate biopsy quality of a novel biopsy needle.
Detailed Description
Prostate biopsy is the golden standard for diagnose of prostate cancer. Transrectal prostate biopsy (TRUSbx) is the most widely used technique. Due to the transrectal path the biopsy needle will bring...
Eligibility Criteria
Inclusion
- Eligible for prostate biopsy
- Signed informed written consent
Exclusion
- None (other than general contra indications for prostate biopsy or patient not willing to participate)
Key Trial Info
Start Date :
September 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04091230
Start Date
September 10 2019
End Date
November 1 2019
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsingborg Hospital
Helsingborg, Skåne County, Sweden, 254 37